June 30, 2016 / 2:27 PM / a year ago

BUZZ-Transition Therapeutics more than doubles on buyout by Opko

1 Min Read

** Canadian drug developer's U.S.-listed shares up 107 pct to $1.45; Toronto-listed stock up 112.4 pct at C$1.89

** U.S.-listed stock rises as much as 111.4 pct, biggest intraday percentage gain in 9 years

** Opko Health Inc to buy Transition, which is developing drug candidates for diabetes and obesity, among others, in all-stock deal valued at about $60 mln, or $1.55 per share

** Opko shares down slightly at $9.26

** Up to Wednesday's close, Transition's U.S.-listed shares had lost about two-thirds of their value this year, while Opko shares had fallen about 8 pct

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below